MICHAEL MALDONADO: Open Payments
NPI 1144976184 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 16 payments from 8 companies in 2025. Trend: 2023 $176 · 2024 $265 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 4 | $149 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $106 |
| Solventum Corporation | 2 | $62 |
| Smith+Nephew, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
Products named: MYRISK, JOURNAVX, ACTIV.A.C., LUTATHERA, OASIS, PICO 7, Wegovy, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
